Perspectives on Biomarker and Surrogate Endpoint Evaluation - Discussion Forum Summary

Following the book's release, the IOM convened a 2-day discussion forum in Washington, DC, in order to provide an opportunity for stakeholders to learn about, react to, and discuss the book. The present volume recounts the discussion forum proceedings, focusing in turn on each represented sector.